AllianceBernstein’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-500,633
Closed -$40.1M 3094
2016
Q4
$40.1M Buy
500,633
+4,040
+0.8% +$321K 0.03% 514
2016
Q3
$39.6M Buy
496,593
+710
+0.1% +$57.3K 0.03% 514
2016
Q2
$38.7M Buy
495,883
+3,069
+0.6% +$219K 0.03% 489
2016
Q1
$27.1M Sell
492,814
-11,904
-2% -$649K 0.02% 597
2015
Q4
$31.2M Sell
504,718
-15,302
-3% -$965K 0.03% 559
2015
Q3
$32.8M Sell
520,020
-972
-0.2% -$69.4K 0.03% 528
2015
Q2
$38.1M Sell
520,992
-8,918
-2% -$644K 0.03% 539
2015
Q1
$34.7M Sell
529,910
-9,892
-2% -$658K 0.03% 569
2014
Q4
$35.1M Sell
539,802
-6,162
-1% -$397K 0.03% 554
2014
Q3
$32.8M Buy
545,964
+653
+0.1% +$42.7K 0.03% 576
2014
Q2
$37.8M Sell
545,311
-31,054
-5% -$2.01M 0.03% 541
2014
Q1
$37.7M Sell
576,365
-23,200
-4% -$1.51M 0.03% 532
2013
Q4
$37.1M Buy
599,565
+54,442
+10% +$3.15M 0.03% 517
2013
Q3
$29.2M Buy
545,123
+7,259
+1% +$374K 0.03% 556
2013
Q2
$24.5M Buy
+537,864
New +$23.3M 0.03% 592

Other funds holding STJ

AllianceBernstein's STJ Position: Q1 2017 in Review

AllianceBernstein sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 500,633 shares — an estimated $40.1M sold.

AllianceBernstein first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $40.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • AllianceBernstein reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • AllianceBernstein sold 500,633 St Jude Medical shares in Q1 2017, an estimated $40.1M.
  • AllianceBernstein first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • AllianceBernstein's St Jude Medical position peaked at $40.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on AllianceBernstein's 13F filing for Q1 2017, filed 11 May 2017.